CEO Jean Jacques Bienaime sold $1.4M of BioMarin Pharmaceutical Inc.

Sold$1,379,861

$82.79Price

16,667Shares

−3%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Thu, Jan 28. Filed Mon, Feb 1, 7:00 PM ET, after the close. Not investment advice.